Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
TCON Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: June 18, 2024
Report Source: 2024 1st Quarter Report
TRACON Pharmaceuticals Inc. Stock Analysis TCON
United States Health Care Nano Cap Report: TRACON Pharmaceuticals Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 17 full-time employees. The company went IPO on 2015-01-30. TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The firm is focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its contract research organization (CRO) independent product development platform to partner with other life science companies to develop and commercialize products in the United States. The Company’s clinical-stage oncology product candidate is TRC102, which is a small molecule that has been studied in Phase 1 and Phase 2 trials for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors and YH001, which is a monospecific investigational cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody. TRC102 is a small molecule in clinical development to reverse resistance to specific chemotherapeutics by inhibiting DNA base excision repair (BER). Its clinical-stage product candidate, Envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma.
Read More TRACON Pharmaceuticals Inc (TCON) Chart
Key Statistics of TRACON Pharmaceuticals Inc (TCON)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.03Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
110.00KAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of TRACON Pharmaceuticals Inc (TCON)
FAQ's for TRACON Pharmaceuticals Inc (TCON)
- According to Musaffa’s Shariah screening methodology, TRACON Pharmaceuticals Inc (TCON) is currently classified as NOT HALAL as of June 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TRACON Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in TRACON Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of TRACON Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of TRACON Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of TRACON Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.